Table 1.
Full sample | Latent trajectory groups | |||||
---|---|---|---|---|---|---|
|
||||||
(n=50) dual
chronic |
(n=95)increasing AOD/
persistent ASB |
(n=152) persistent AOD/
adolescent ASB |
(n=62) decreasing drugs/
persistent ASB |
(n=165)
resolved |
||
Baseline variables | ||||||
Recruitment source | ||||||
Alternative school or community |
33.0% | 33.0% | 34.7% | 32.2% | 35.5% | 33.9% |
Treatment facilities | 43.9% | 43.9% | 43.2% | 45.1% | 50.0% | 37.6% |
Juvenile justice | 23.1% | 23.1% | 22.1% | 22.4% | 14.5% | 25.5% |
Sex (proportion male) | 73.7% | 92.0% | 88.4% | 82.9% | 62.9% | 55.2 |
Race (proportion white) | 51% | 52% | 56% | 59% | 44% | 44% |
MDD symptom count: M (SD) | 1.2 (2.2) | 1.2 (2.4) | 1.0 (2.2) | 1.2 (2.1) | 1.3 (2.3) | 1.3 (2.3) |
Past-year MDD diagnosis | 12.0% | 12.0% | 10.5% | 11.8% | 12.9% | 12.7 |
Follow-up depression
outcomes |
||||||
CES-D score: M (SD) | 12.3 (9.8) | 16.9 (12.1) | 13.3 (11.2) | 11.3 (8.8) | 13.9 (10.4) | 10.7 (8.3) |
MDD symptom count: M (SD) | 0.93 (2.3) | 1.5 (3.0) | 1.0 (2.5) | 0.7 (1.9) | 1.7 (3.0) | 0.7 (1.7) |
MDD diagnosis | 8.9% | 16.0% | 10.5% | 6.6% | 19.4% | 4.2 |
Suicidal ideation | 17% | 50% | 10% | 0% | 25% | 0% |